Eyebright Medical Technology (Beijing) Co., Ltd. (SHA:688050)

Market Cap	7.28B -52.5%
Revenue (ttm)	1.63B +7.8%
Net Income	237.46M -39.7%
EPS	1.23 -40.7%
Shares Out	193.44M
PE Ratio	30.66
Forward PE	19.84
Dividend	0.32 (0.81%)
Ex-Dividend Date	Jun 22, 2026

Volume	1,637,038
Open	37.53
Previous Close	37.55
Day's Range	37.15 - 37.93
52-Week Range	35.23 - 80.00
Beta	0.20
Analysts	Buy
Price Target	52.00 (+38.19%)
Earnings Date	Aug 26, 2026

About SHA:688050

Eyebright Medical Technology (Beijing) Co., Ltd. engages in development, production, and commercialization of ophthalmic medical devices in China and internationally. The company provides intraocular lens, trimmers, capsular tension ring, defocus lense, orthokeratology, and contact lenses in the areas of surgical treatment, myopia management, and consumer vision care. It also offers solutions for ophthalmic surgery, refractive error correction, and optometry consumption. The company was founded in 2010 and is headquartered in Beijing, China.

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 2010
• Employees: 2,331
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 688050

Financial Performance

In 2025, SHA:688050's revenue was 1.48 billion, an increase of 5.15% compared to the previous year's 1.41 billion. Earnings were 268.17 million, a decrease of -30.96%.

Analyst Summary

According to 7 analysts, the average rating for 688050 stock is "Buy." The 12-month stock price target is ¥52.00, which is an increase of 38.19% from the latest price.

Price Target

¥52.00

(38.19% upside)

Analyst Consensus: Buy

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Sep 14, 2026

Data Sources Report a data error